Drug
Cenderitide clinical trials
Also written CD-NP.
- studies test it
- 12
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
12 studies that test it; most in 2007 (2)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 9
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 5
Nile Therapeutics (5) · Mayo Clinic (4) · Capricor Inc. (2) · John A. Schirger (1)
Studies
Open first, then newest update. How each study uses cenderitide is read from its arms, and is right about nine times in ten.
Testing it · 12
- CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular FunctionCompletedPhase 1Mayo ClinicNCT02071602Written as CD-NP
- Safety Study of Cenderitide in Stable Chronic Heart FailureCompletedPhase 2Capricor Inc.NCT02359227Written as Cenderitide
- Safety Study of Cenderitide in Chronic Stable Heart Failure With Moderate Renal ImpairmentCompletedPhase 1/2Capricor Inc.NCT02603614Written as Cenderitide
- Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device SupportWithdrawnPhase 1Mayo ClinicNCT03091998Written as CD-NP
- Safety Study of Chimeric Natriuretic Peptide(CD-NP) in Stable LVAD PatientsCompletedPhase 1Mayo ClinicNCT01750905Written as CD-NP
- Effects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal DysfunctionWithdrawnPhase 1John A. SchirgerNCT01407900Written as CD-NP
- PK/PD Study of Subcutaneous Cenderitide Infusion in CHF PatientsCompletedPhase 1Nile TherapeuticsNCT01316432Written as Cenderitide
- CD-NP in Subjects With Stable Chronic Heart FailureCompletedPhase 1Mayo ClinicNCT00620308Written as CD-NP
- Study to Assess the Safety and Efficacy of CD-NP in the Treatment of Patients With Acute Decompensated Heart FailureCompletedPhase 2Nile TherapeuticsNCT00839007Written as CD-NP
- Study to Assess Hemodynamic Effects, Safety and Tolerability of Chimeric Natriuretic Peptide (CD-NP) in Patients With Stabilized Acute Heart Failure (AHF)CompletedPhase 2Nile TherapeuticsNCT00699712Written as CD-NP (Chimeric natriuretic peptide)
- Safety Study of CD-NP in Heart FailureCompletedPhase 1Nile TherapeuticsNCT00557661Written as CD-NP
- Safety and Pharmacodynamic Study of CD-NPCompletedPhase 1Nile TherapeuticsNCT00482937Written as CD-NP
Codes
What other systems call cenderitide · ClinicalTrials.gg INT006157
- MeSH (NLM) C575835cenderitideOne source NLM
- UNII (FDA) 9NKZ9LYZ06CENDERITIDEConfirmed FDA, NLM, Wikidata
- Wikidata Q5009769cenderitideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C171663CenderitideOne source FDA
- DrugBank DB11777One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C575835 | cenderitide | One source NLM |
| UNII (FDA) | 9NKZ9LYZ06 | CENDERITIDE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q5009769 | cenderitide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C171663 | Cenderitide | One source FDA |
| DrugBank | DB11777 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.